Loreto
Carmona Ortells
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (10)
2024
-
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort
Lupus Science and Medicine, Vol. 11, Núm. 1
2020
-
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: A multicentric matched cohort study
Annals of the Rheumatic Diseases, Vol. 79, Núm. 12, pp. 1544-1549
2014
-
Documento práctico para el uso de abatacept subcutáneo
Reumatologia Clinica, Vol. 10, Núm. 4, pp. 218-226
2013
-
El uso de abatacept en artritis reumatoide: Revisión de la evidencia y recomendaciones
Reumatologia Clinica, Vol. 9, Núm. 1, pp. 5-17
2010
-
Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression
Reumatologia Clinica, Vol. 6, Núm. 1, pp. 63-68
2009
-
Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy
Clinical and Experimental Rheumatology, Vol. 27, Núm. 6, pp. 920-925
2006
-
Riesgo cardiovascular en la artritis reumatoide. ¿Hasta dónde?
Reumatologia Clinica
-
Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period
Arthritis Research and Therapy, Vol. 8, Núm. 1
2005
-
Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists
Arthritis and Rheumatism, Vol. 52, Núm. 6, pp. 1766-1772
2003
-
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report
Arthritis and Rheumatism, Vol. 48, Núm. 8, pp. 2122-2127